Review Article
Vaccines against Human Carcinomas: Strategies to Improve Antitumor Immune Responses
Table 2
Human carcinoma antigens.
| | Carcinoma antigens* | | Tumor-specific antigens | Tumor-associated antigens |
| | Mutated molecules | Carcinoembryonic antigen (CEA) | | K-RAS | Mucin 1 (MUC-1) | | p53 | Prostate-specific antigen (PSA) | | Fusion molecules | Prostate acid phosphatase (PAP) | | BCR-ABL | Prostate stem-cell antigen (PSCA) | | Brachyury | | Virally-derived molecules | TERT | | HPV-16 E6, E7 | Wilm’s tumor 1 (WT1) | | EBNA1, LMP1 and LMP2 | Her-2/neu | | Sox-2 | | NY-ESO-1 | | Cyclin D1 | | Mesothelin | | Survivin |
|
|
is only a partial list of antigens for human carcinomas.
|
